Inhibitors of polo-like kinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8541418
APP PUB NO 20110207716A1
SERIAL NO

12974622

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds having a structure according to Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ELAN PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adler, Marc Orinda, US 22 79
Anderson, John P San Francisco, US 62 1651
Artis, Dean R Kensington, US 81 2922
Aubele, Danielle Burlingame, US 22 97
Beroza, Paul Belmont, US 6 3
Bowers, Simeon Oakland, US 47 104
Galemmo, Robert A San Francisco, US 12 101
Hom, Roy K San Francisco, US 24 10
Neitz, R Jeffrey San Francisco, US 43 78
Sealy, Jennifer Oakland, US 23 91
Truong, Anh Burlingame, US 480 1303
Ye, Xiaocong Michael Palo Alto, US 12 60
Zhu, Yong-Liang Fremont, US 58 1009

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00